Cargando…
Systemic treatment for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor and innovative immunotherapy demonstrate new prom...
Autores principales: | Aggarwal, Manushi, Arain, Abeer, Jin, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Medical Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160617/ https://www.ncbi.nlm.nih.gov/pubmed/30276361 http://dx.doi.org/10.1016/j.cdtm.2018.08.003 |
Ejemplares similares
-
Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update
por: Rizzo, Alessandro, et al.
Publicado: (2022) -
The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma
por: Parikh, Neehar D., et al.
Publicado: (2016) -
Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma
por: Yoshikawa, Sayuri, et al.
Publicado: (2023) -
Perspective: The Mechanobiology of Hepatocellular Carcinoma
por: Loneker, Abigail E., et al.
Publicado: (2021) -
Is hepatocellular carcinoma surveillance in high-risk populations effective?
por: Onyirioha, Kristeen, et al.
Publicado: (2020)